Express Scripts (ESRX): Today's Featured Health Services Winner

The health services industry closed the day up 2%. Mela Sciences Inc ( MELA), World Heart Corporation ( WHRT), Kips Bay Medical Inc ( KIPS), and Uroplasty Inc ( UPI) were all winners today within the health services industry with Express Scripts ( ESRX) being today's featured health services winner. Express Scripts rose 35 cents (1%) to $36.06 on average volume. Throughout the day, 10.2 million shares of Express Scripts exchanged hands as compared to its average daily volume of 10.3 million shares.

Express Scripts, Inc. provides a range of pharmacy benefit management (PBM) services in North America. Express Scripts has a market cap of $18.1 billion and is part of the health care sector. The company has a P/E ratio of 15.1, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7. Shares are down 33.9% year to date as of the close of trading on Monday.

TheStreet Ratings rates Express Scripts as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, revenue growth, notable return on equity, solid stock price performance and compelling growth in net income. We feel these strengths outweigh the fact that the company has had generally poor debt management on most measures that we evaluated.

On the negative front, Gentiva Health Services Inc ( GTIV), Amedisys Inc ( AMED), IntegraMed America Inc ( INMD), and Pressure BioSciences Inc ( PBIO) were all losers within the health services industry with Endologix Inc ( ELGX) being today's health services industry Loser Spotlight stock.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Global Stocks Retreat as U.S.-China Trade War Intensifies

Global Stocks Retreat as U.S.-China Trade War Intensifies

Billionaire Investor Tim Draper Explains Why Bitcoin Will Hit $250,000 in 2022

Billionaire Investor Tim Draper Explains Why Bitcoin Will Hit $250,000 in 2022

To Think a Trade War's Still Just a Threat Is the Dumbest Thing on Wall Street

To Think a Trade War's Still Just a Threat Is the Dumbest Thing on Wall Street

M&A Trends Still on Investors' Minds Despite Worries Over Tariffs -- ICYMI

M&A Trends Still on Investors' Minds Despite Worries Over Tariffs -- ICYMI

Dow Falls as U.S. Imposes Tariffs on $50 Billion of Chinese Goods

Dow Falls as U.S. Imposes Tariffs on $50 Billion of Chinese Goods